Skip to main content
. 2021 May 5;30(19-20):2948–2959. doi: 10.1111/jocn.15802

TABLE 1.

Demographic and clinical characteristics of the participants (n = 785)

Variables n (%) Variables n (%)
Gender Marital status
Male 375 (47.77) With spouse 712 (90.70)
Female 410 (52.23) Without spouse 73 (9.30)
Nationality Occupation status
Han nationality 779 (99.2) Not retired 132 (16.82)
Minority nationality 6 (0.8) Retired 653 (83.18)
Age Way of living
≤59 153 (19.49) Live alone 29 (3.69)
60–79 500 (63.69) Live with non‐spouse 61 (7.77)
>80 132 (16.82) Live with spouse and non‐spouse 260 (33.12)
Live with spouse only 435 (55.42)
Education level Household monthly income per capita
Middle school education or less 313 (39.88) ≤1800 RMB 58 (7.38)
Senior high school education 231 (29.42) 1801–2800 RMB 220 (28.03)
Diploma education 131 (16.69) 2801–5000 RMB 375 (47.77)
Bachelor degree or above 110 (14.01) >5000 RMB 132 (16.82)
Insurance status Smoking
Basic medical insurance (BMI) 33 (4.20) Yes 110 (14.01)
BMI+special outpatient subsidy for diabetes (SOSD) 369 (47.01) No 675 (85.99)
BMI+SOSD+supplementary Medical insurance 364 (46.37)

Alcohol drinking

Yes

86 (10.96)

Free medical care 19 (2.42) No 699 (89.04)
Diabetes family history Duration of diabetes
Yes 165 (21.02) <5 years 226 (28.79)
No 606 (77.20) 5–10 years 331 (42.17)
Not sure 14 (1.78) >10 years 228 (29.04)
Current fast glucose level The latest HbA1c level
≤6.99 mmol/L 470 (59.87) ≤6.99% 452 (57.58)
≥7.0 mmol/L 315 (40.13) ≥7.0% 252 (32.10)
Not clear 81 (10.32)
Diabetes therapy Presence of diabetes‐related Comorbidities/ complications
Lifestyle adjustment 12 (1.53) None 103 (13.13)
Oral hypoglycaemic therapy 576 (73.37) Hypertension or/and hyperlipidaemia 198 (25.22)
Injection of insulin 24 (3.06) Other chronic complications 49 (6.24)
Oral hypoglycaemic therapy+Injection of insulin 173 (22.04) Hypertension or/and hyperlipidaemia +other chronic complications 435 (55.41)

Other chronic complications: cardiovascular disease, cerebrovascular disease, diabetic nephropathy, diabetic retinopathy, lower extremity vascular disease and peripheral neuropathy.